Chapter

HIV/AIDS

Edited by James Harrison, Kunal Kulkarni, Mohamed Baguneid and Bernard Prendergast

in Oxford Handbook of Key Clinical Evidence

Published on behalf of Oxford University Press

Published in print November 2009 | ISBN: 9780199234073
Published online August 2010 | e-ISBN: 9780199598830 | DOI: http://dx.doi.org/10.1093/med/9780199234073.003.0012

Series: Oxford Medical Handbooks

HIV/AIDS

More Like This

Show all results sharing this subject:

  • Medical Statistics and Methodology

GO

Show Summary Details

Preview

Introduction - Antiretroviral treatmentBoosted vs unboosted protease inhibitors - Initial treatment: number of nucleoside agents - Nucleoside reverse transcriptase inhibitor: optimal agents - Continuous vs intermittent antiretrovirals - Hepatitis C co-infectionHIV and hepatitis C co-infection - Cardiovascular riskAntiretroviral therapy and cardiovascular risk

Chapter.  3735 words. 

Subjects: Medical Statistics and Methodology

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.